News

China’s Sinopharm has applied for regulatory approval to launch a COVID-19 vaccine for public use, but nearly 1 million people have already taken experimental shots

Chinese pharmaceutical giant Sinopharm on Tuesday applied to the country’s health regulators to launch its COVID-19 vaccines for public use, based on multiple news reports. However, close to a million people have already been injected with experimental shots since the Chinese government authorised the vaccines for emergency use in July. […]
China’s Sinopharm has applied for regulatory approval to launch a COVID-19 vaccine for public use, but nearly 1 million people have already taken experimental shots
Markets

Inovio tanks 40% after pausing coronavirus vaccine trial, trading halted

Inovio Pharmaceuticals tumbled as much as 40% in early Monday trading after the biotech firm announced a temporary hold on its coronavirus vaccine’s phase 2/3 trial. The study is on “partial clinical hold” until questions asked by the Food and Drug Administration are answered, Inovio said in a press release. […]
Inovio tanks 40% after pausing coronavirus vaccine trial, trading halted
Markets

Novavax surges 10% after it begins phase 3 trial of COVID-19 vaccine

Novavax said Thursday it initiated a Phase 3 trial of its COVID-19 vaccine in the UK. The trial will enroll up to 10,000 volunteers across the UK to assess the NVX-CoV2373 vaccine candidate. Novavax has scaled up its manufacturing capacity in anticipation of developing a successful COVID-19 vaccine, and will […]
Novavax surges 10% after it begins phase 3 trial of COVID-19 vaccine